Kush Bottles to Present at the LD Micro Investor Conference on December 6, 2016

Thursday, December 1, 2016 General News J E 4

SANTA ANA, Calif., Dec. 1, 2016 /PRNewswire/ -- Kush Bottles, Inc. (OTCQB: KSHB), a leading provider of packaging, supplies, accessories and branding solutions for the regulated cannabis industry, has been invited to present at the LD Micro Main Event investor conference being held December 6-8, 2016 at the Luxe Sunset Hotel in Los Angeles, CA.

Kush Bottles CEO Nick Kovacevich is scheduled to present on Tuesday, December 6 at 3:30 p.m. PST, with one-on-one meetings held throughout the day. He will also participate in a panel discussion on the future of the cannabis industry at 5:30 p.m. PST, along with executives from TerraTech, MassRoots and Electrum Partners.

For more information about the conference or to schedule a one-on-one meeting with Kush Bottles management, please contact your LD Micro representative.

About Kush Bottles

Kush Bottles, Inc. (OTCQB: KSHB) provides packaging products and solutions to producers, processers and retailers operating in the regulated medical and recreational cannabis industry. Founded in 2010, Kush Bottles has sold more than 100 million bottles and regularly services more than 1,000 customers across the United States and Canada. The company primarily services the business-to-business market, which includes legally operated medical and adult-use dispensaries, growers and marijuana-infused product (MIP) manufacturers. Kush Bottles aims to be the gold standard for responsible branding and packaging in the cannabis industry.

Kush Bottles has no direct involvement with cannabis plants or extracts.

The company has been featured in media nationwide, including CNBC, Los Angeles Times,, Entrepreneur, and Inc. Magazine. For more information, visit or call (888)-920-5874.


Website: Instagram:

Company ContactRyan SelewiczDirector of

Investor RelationsLioliosCody Slach or Sean



To view the original version on PR Newswire, visit:

SOURCE Kush Bottles, Inc.



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Healthcare IT and Advanced Analytics Offer Billion...
ViraCyte Announces Oral Presentations on Clinical ...